Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/12816
標題: 犬淋巴瘤病患預後分析及以聚合酶鏈鎖反應與免疫組織化學染色方法鑑定腫瘤細胞來源及表現型
Prognostic variables, and clonality and pheno-typing by polymerase chain reaction and immu-nohistochemical methods in canine lymphomas
作者: 楊伊平
Yang, Yi-Ping
關鍵字: Dog

Gene rearrangement
Immunophenotype
Lymphoma
Prognostic factors
基因重組
免疫性狀
淋巴瘤
預後因子
出版社: 獸醫學系暨研究所
引用: Abbo, A.H., Lucroy, M.D., 2007. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006). Journal of the American Veterinary Medical Association 231, 1836-1842. Beale, K.M., Bolon, B., 1993. Canine cutaneous lymphosarcoma epitheliotropic and non epitheliotropic, a retrospective study. In: Ihrke, P.J., Mason, I.S., White, S.D. (Eds.), Advances in Veterinary Dermatology. Vol. II. Pergamon Press, New York, USA, pp. 273-284. Beaver, L.M., Strottner, G., Klein, M.K., 2010. Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008). Journal of the American Veterinary Medical Association 237, 1052-1055. Bergman, P.J., Ogilvie, G.K., Powers, B.E., 1996. Monoclonal antibody C219 immuno-histochemistry against P-glycoprotein: sequential analysis and predictive ability in dogs with lymphoma. Journal of Veterinary Internal Medicine 10, 354-359. Brodsky, E.M., Maudlin, G.N., Lachowicz, J.L., Post, G.S., 2009. Asparaginase and MOPP treatment of dogs with lymphoma. Journal of Veterinary Internal Medicine 23, 578-584. Burnett, R.C., Vernau, W., Modiano, J.F., Olver, C.S., Moore, P.F., Avery, A.C., 2003. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Veterinary Pathology 40, 32-41. Carter, R.F., Valli, V.E., Lumsden, J.H., 1986. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer In-stitute Working Formulation. Canadian Journal of Veterinary Research 50, 154-164. Chaubert, P., Baur Chaubert, A.S., Sattler, U., Forster, U., Bornand, V., Suter, M., Welle, M., 2010. Improved polymerase chain reaction-based method to detect ear-ly-stage epitheliotropic T-cell lymphoma (mycosis fungoides) in formalin-fixed, paraffin-embedded skin biopsy specimens of the dog. Journal of Veterinary Diag-nostic Investigation 22, 20-29. Choi, Y., Greenberg, S.J., Du, T.L., Ward, P.M., Overturf, P.M., Brecher, M.L., Ballow, M., 1996. Clonal evolution in B-lineage acute lymphoblastic leukemia by contem-poraneous VH-VH gene replacements and VH-DJH gene rearrangements. Blood 87, 2506-2512. Chun, R., 2009. Lymphoma: which chemotherapy protocol and why? Topics in Com-panion Animal Medicine 24, 157-162. Cook, A.K., Wright, Z.M., Suchodolski, J.S., Brown, M.R., Steiner, J.M., 2009. Preva-lence and prognostic impact of hypocobalaminemia in dogs with lymphoma. Jour-nal of the American Veterinary Medical Association 235, 1437-1441. Daters, A.T., Mauldin, G.E., Mauldin, G.N., Brodsky, E.M., Post, G.S., 2010. Evalua-tion of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma. Veterinary and Comparative Oncology 8, 11-22. Davey, M.P., Bongiovanni, K.F., Kaulfersch, W., Quertermous, T., Seidman, J.G., Hershfield, M.S., Kurtzberg, J., Haynes, B.F., Davis, M.M., Waldmann, T.A., 1986. Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation. Proceedings of the Na-tional Academy of Sciences of the United States of America 83, 8759-8763. Dobson, J.M., Blackwood, L.B., Mclnnes, E.F., Bostock, D.E., Nicholls, P., Hoather, T.M., Tom, B.D., 2001. Prognostic variables in canine multicentric lymphosarcoma. The Journal of Small Animal Practice 42, 377-384. Dupire, S., Coiffier, B., 2010. Targeted treatment and new agents in diffuse large B cell lymphoma. International Journal of Hematology 92, 12-24. Endo, Y., Cho, K.W., Nishigaki, K., Momoi, Y., Nishimura, Y., Mizuno, T., Goto, Y., Watari, T., Tsujimoto, H., Hasegawa, A., 1997. Molecular characteristics of ma-lignant lymphomas in cats naturally infected with feline immunodeficiency virus. Veterinary Immunology and Immunopathology 57, 153-167. Ferrer, L., Fondevila, D., Rabanal, R., Ramis, A., 1992. Detection of T lymphocytes in canine tissue embedded in paraffin wax by means of antibody to CD3 antigen. Journal of Comparative Pathology 106, 311-314. Flory, A.B., Rassnick, K.M., Erb, H.N., Garrett, L.D., Northrup, N.C., Selting, K.A., Phillips, B.S., Locke, J.E., Chretin, J.D., 2011. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyc-lophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). Journal of the American Veterinary Medical Association 238, 501-506. Fontaine, J., Bovens, C., Bettenay, S., Mueller, R.S., 2009. Canine cutaneous epithelio-tropic T-cell lymphoma: a review. Veterinary and Comparative Oncology 7, 1-14. Fontaine, J., Heimann, M., Day, M.J., 2010. Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases. Veterinary Dermatology 21, 267-275. Fournel-Fleury, C., Ponce, F., Felman, P., Blavier, A., Bonnefont, C., Chabanne, L., Marchal, T., Cadore, J.L., Goy-Thollot, I., Ledieu, D., Ghernati, I., Magnol, J.P., 2002. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Veterinary Pathology 39, 92-109. Fry, M.M., Vernau, W., Pesavento, P.A., Bromel, C., Moore, P.F., 2003. Hepatosplenic lymphoma in a dog. Veterinary Pathology 40, 556-562. Gabor, L.J., Love, D.N., Malik, R., Canfield, P.J., 2001. Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Australian Veterinary Journal 79, 540-545. Garrett, L.D., Thamm, D.H., Chun, R., Dudley, R., Vail, D.M., 2002. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lym-phoma. Journal of Veterinary Internal Medicine 16, 704-709. Greenlee, P.G., Filippa, D.A., Quimby, F.W., Patnaik, A.K., Calvano, S.E., Matus, R.E., Kimmel, M., Hurvitz, A.I., Lieberman, P.H., 1990. Lymphomas in dogs: a mor-phologic, and immunologic, and clinical study. Cancer 66, 480-490. Gross, T.L., Ihrke, P.J., Walder, E.J., Affolter, V.K., 2005. Skin Diseases of the Dog and Cat - Clinical and Histopathologic Diagnosis, Second ed. Blackwell Science, Oxford, UK, pp. 876-888. Guija de Arespacochaga, A.G., Schwendenwein, I., Weissenbock, H., 2007. Retrospec-tive study of 82 cases of canine lymphoma in Austria based on the Working For-mulation and immunophenotyping. Journal of Comparative Pathology 136, 186-192. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E., Warnke, R.A., 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361-1392. Jacobs, R.M., Messick, J.B., Valli, V.E., 2002. Tumors of the hemolymphatic system. In: Meuten, D.J. (Ed.), Tumors in Domestic Animals, fourth ed. Blackwell, Iowa, USA, pp. 119-198. Jagielski, D., Lechowski, R., Hoffmann-Jagielska, M., Winiarczyk, S., 2002. A retros-pective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000). Journal of Veterinary Medicine (A, Physiology, Pathology, Clinical Medicine) 49, 419-424. Jeffreys, A.B., Knapp, D.W., Carlton, W.W., Thomas, R.M., Bonney, P.L., deGortari, A., Lucroy, M.D., 2005. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. Journal of the American Animal Hos-pital Association 41, 221-226. Jones, M., Cordell, J.L., Beyers, A.D., Tse, A.G., Mason, D.Y., 1993. Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. Journal of Immunology 150, 5429-5435. Kaiser, C.I., Fidel, J.L., Roos, M., Kaser-Hotz, B., 2007. Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma. Journal of the American Animal Hospital Association 43, 85-92. Kiupel, M., Teske, E., Bostock, D., 1999. Prognostic factors for treated canine malig-nant lymphoma. Veterinary Pathology 36, 292-300. Lee, J.J., Hughes, C.S., Fine, R.L., Page, R.L., 1996. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer 77, 1892-1898. MacEwen, E.G., Patnaik, A.K., Wilkins, R.J., 1977. Diagnosis and treatment of canine hematopoietic neoplasms. The Veterinary Clinics of North America 7, 105-118. Malik, S.M., Liu, K., Qiang, X., Sridhara, R., Tang, S., McGuinn, W.D. Jr., Verbois, S.L., Marathe, A., Williams, G.M., Bullock, J., Tornoe, C., Lin, S.C., Ocheltree, T., Vialpando, M., Kacuba, A., Justice, R., Pazdur, R., 2010. Folotyn (pralatrexate in-jection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary. Clinical Cancer Research 16, 4921-4927. Marconato, L., Stefanello, D., Valenti, P., Bonfanti, U., Comazzi, S., Roccabianca, P., Caniatti, M., Romanelli, G., Massari, F., Zini, E., 2011. Predictors of long-term survival in dogs with high-grade multicentric lymphoma. Journal of the American Veterinary Medical Association 238, 480-485. Mellanby, R.J., Herrtage, M.E., Dobson, J.M., 2002. Treatment of canine lymphoma by veterinarians in first opinion practice in England. The Journal of Small Animal Practice 43, 198-202. Milman, G., Smith, K.C., Erles, K., 2011. Serological detection of Epstein-Barr virus infection in dogs and cats. Veterinary Microbiology 150, 15-20. Owen, L.N., 1980. WHO. In: Owen, L.N. (Ed.), TNM Classification of Tumors in Do-mestic Animals. Geneva, p. 47. Pastor, M., Chalvet-Monfray, K., Marchal, T., Keck, G., Magnol, J.P., Fournel-Fleury, C., Ponce, F., 2009. Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. Journal of Veterinary Internal Medicine 23, 301-310. Pelicci, P.G., Knowles, D.M. II, Dalla Favera, R., 1985. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. The Journal of Experimental Medicine 162, 1015-1024. Ponce, F., Magnol, J.P., Ledieu, D., Marchal, T., Turinelli, V., Chalvet-Monfray, K., Fournel-Fleury, C., 2004. Prognostic significance of morphological subtypes in ca-nine malignant lymphomas during chemotherapy. Veterinary Journal 167, 158-166. Ponce, F., Marchal, T., Magnol, J.P., Turinelli, V., Ledieu, D., Bonnefont, C., Pastor, M., Delignette, M.L., Fournel-Fleury, C., 2010. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Veterinary Pathology 47, 414-433. Rassnick, K.M., McEntee, M.C., Erb, H.N., Burke, B.P., Balkman, C.E., Flory, A.B., Kiselow, M.A., Autio, K., Gieger, T.L., 2007. Comparison of 3 protocols for treat-ment after induction of remission in dogs with lymphoma. Journal of Veterinary Internal Medicine 21, 1364-1373. Rebhun, R.B., Kent, M.S., Borrofka, S.A., Frazier, S., Skorupski, K., Rodriguez, C.O., 2011. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma. Veterinary and Comparative Oncology 9, 38-44. Remmele, W., Stegner, H.E., 1987. Recommendation for uniform definition of an im-munoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Der Pathologe 8, 138-140. Rojas, H.C., Merino, M.C., Ghiringhelli, M.J.P., Rodriguez, A.J.R., Martinez, L.F., Jen-sen, R.W., 2011. Lymphomas associated with human immunodeficiency virus in-fection: retrospective review of medical records. Revista Medica de Chile 139, 27-35. Rosenberg, M.P., Matus, R.E., Patnaik, A.K., 1991. Prognostic factors in dogs with lymphoma and associated hypercalcemia. Journal of Veterinary Internal Medicine 5, 268-271. Santoro, D., Marsella, R., Hernandez, J., 2007. Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study. Veterinary Dermatology 18, 101-106. Scott, D.W., Miller, W.H., Griffin, C.E.., 2001. Muller and Kirk's Small Animal Der-matology, Sixth ed. W.B. Saunders Company, Philadelphia, USA, pp. 1330-1340. Shapiro, P.E., Pinto, F.J., 1994. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma): a review of 222 biopsies, including newly described patterns and the earliest pathologic changes. American Journal of Sur-gical Pathology 18, 645-667. Shelton, G.H., Grant, C.K., Cotter, S.M., Gardner, M.B., Hardy, W.D. Jr., DiGiacomo, R.F., 1990. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). Journal of Acquired Immune Deficiency Syndromes 3, 623-630. Simon, D., Moreno, S.N., Hirschberger, J., Moritz, A., Kohn, B., Neumann, S., Jurina, K., Scharvogel, S., Schwedes, C., Reinacher, M., Beyerbach, M., Nolte, I., 2008. Effi-cacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma. Journal of the American Veterinary Medical Association 232, 879-885. Teske, E., 1994. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. The Veterinary Quarterly 16, 209-219. Teske, E., van Heerde, P., Rutteman, G.R., Kurzman, I.D., Moore, P.F., MacEwen, E.G., 1994. Prognostic factors for treatment of malignant lymphoma in dogs. Journal of the American Veterinary Medical Association 205, 1722-1728. Thilakaratne, D.N., Mayer, M.N., MacDonald, V.S., Jackson, M.L., Trask, B.R., Kidney, B.A., 2010. Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cyto-logic smears and peripheral blood. The Canadian Veterinary Journal 51, 79-84. Thompson, S.D., Manzo, A.R., Pelkonen, J., Larche, M., Hurwitz, J.L., 1991. Deve-lopmental T cell receptor gene rearrangements: relatedness of the alpha/beta and gamma/delta T cell precursor. European Journal of Immunology 21, 1939-1950. Tomiyasu, H., Takahashi, M., Fujino, Y., Ohno, K., Tsujimoto, H., 2010. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophospha-mide, and doxorubicin in dogs with lymphoma that underwent a combination mul-tidrug chemotherapy protocol. The Journal of Veterinary Medical Science 72, 1391-1397. Vail, D.M., Michels, G.M., Khanna, C., Selting, K.A., London, C.A., 2010. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0) - a Veterinary Cooperative Oncology Group (VCOG) consensus document. Veterinary and Com-parative Oncology 8, 28-37. Vail, D.M., Young, K.M., 2007. Canine lymphoma and lymphoid leukemia. In: Withrow, S.J., Vail, D.M. (Eds.), Withrow and MacEwen's Small Animal Clinical Oncology, fourth ed. W.B. Saunders, St. Louis, USA, pp. 699-733. Valli, V.E., Jacobs, R.M., Parodi, A.L., Vernau, W., Moore, P.F., 2002. WHO International Histological Classification of Hematopoietic Tumors of Domestic Animals. Second series, vol. VIII. Armed Forces Institute of Pathology, Washington, DC, p. 190. Valli, V.E., Vernau, W., de Lorimier, L.P., Graham, P.S., Moore, P.F., 2006. Canine in-dolent nodular lymphoma. Veterinary Pathology 43, 241-256. van Dongen, J.J., Langerak, A.W., Bruggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., Delabesse, E., Davi, F., Schuuring, E., Garcia-Sanz, R., van Krieken, J.H., Droese, J., Gonzalez, D., Bastard, C., White, H.E., Spaargaren, M., Gonzalez, M., Parreira, A., Smith, J.L., Morgan, G.J., Kneba, M., Macintyre, E.A., 2003. Design and standardization of PCR primers and protocols for detection of clonal immu-noglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257-2317. Vezzali, E., Parodi, A.L., Marcato, P.S., Bettini, G., 2010. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Veterinary and Comparative Oncology 8, 38-49. Wilkerson, M.J., Dolce, K., Koopman, T., Shuman, W., Chun, R., Garrett, L., Barber, L., Avery, A., 2005. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Veterinary Immunology and Immunopathology 106, 179-196. Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerroni, L., Chimenti, S., Diaz-Perez, J.L., Geerts, M.L., Goos, M., Knobler, R., Ralfkiaer, E., Santucci, M., Smith, N., Wechsler, J., van Vloten, W.A., Meijer, C.J., 1997. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90, 354-371. Yagihara, H., Tamura, K., Isotani, M., Ono, K., Washizu, T., Bonkobara, M., 2007. Ge-nomic organization of the T-cell receptor γ gene and PCR detection of its clonal rearrangement in canine T-cell lymphoma/leukemia. Veterinary Immunology and Immunopathology 115, 375-382. Yamazaki, J., Takahashi, M., Setoguchi, A., Fujino, Y., Ohno, K., Tsujimoto, H., 2010. Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study. Journal of Veterinary Internal medicine 24, 897-903. Zaki, M.A., Wada, N., Kohara, M., Ikeda, J., Hori, Y., Fujita, S., Ogawa, H., Sugiyama, H., Hino, M., Kanakura, Y., Morii, E., Aozasa, K., 2011. Presence of B-cell clones in T-cell lymphoma. European Journal of Haematology 86, 412-419. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., Santesson, L., 1970. EBV DNA in biopsies of Burkitt tumors and anaplastic carci-nomas of the nasopharynx. Nature 228, 1056-1058.
摘要: 淋巴瘤為犬隻最常見的血液來源惡性腫瘤,其中免疫性狀為近年來廣為研究的預後因子之一,以聚合酶鍊鎖反應偵側抗原受體重組方法擴展對於犬淋巴瘤的診斷與腫瘤細胞來源鑑定。本實驗之研究目的為(一)探討影響接受不同化學治療犬隻的預後變因與(二)比較以免疫組織化學染色及聚合酶鍊鎖反應方法作為判定腫瘤細胞來源的敏感性。研究對象包含80個多中心型及10個皮膚原發型之淋巴瘤病犬。結果顯示在犬多中心型淋巴瘤治療上,以單一doxorubicin藥物及多種藥物合併治療之病犬,於無疾病進展時間及存活時間並無明顯差異,然而以單一doxorubicin治療的犬隻有較高的腫瘤完全反應率;免疫性狀為B細胞的病犬達到腫瘤完全反應的可能性為具T細胞性狀犬隻的九倍(P = 0.089)。臨床亞期、化療前P-glycoprotein表現量及腫瘤對化療的反應顯著影響病犬存活時間。於66個淋巴瘤病例以免疫組織化學染色及聚合酶鍊鎖反應鑑定腫瘤細胞來源分析中,多中心型淋巴瘤包含78.6% (44/56) B細胞、12.5% (7/56) T細胞及8.9% (5/56)細胞來源無法確定的淋巴瘤病例,所有(10個)皮膚型淋巴瘤病例皆具T細胞性狀;雙重表現型及基因型分別在兩個多中心型淋巴瘤病例發現。整體而言,在所有淋巴腫瘤細胞來源分析結果中,免疫組織化學染色較聚合酶鍊鎖反應有較高的敏感性(分別為93.4%及87.0%)。
Lymphoma is the most common hematopoietic malignancy in dogs, and immu-nophenotype is one of the most important prognostic factors studied in the past decade. Polymerase chain reaction (PCR) for antigen receptor rearrangement (PARR) has ex-panded the diagnosis and clonality assay in canine lymphomas. The aim of this study was to define the prognostic variables among dogs that received different chemothera-peutic protocols, and to compare the sensitivity of immunohistochemical (IHC) staining with PCR assay in the determination of tumor lineage. Eighty multicentric and 10 primary cutaneous lymphomas were included. A single-agent doxorubicin protocol presented with a similar efficacy regarding the progression-free and survival times, whereas a significantly higher complete response (CR) rate, with the combination pro-tocol in dogs with multicentric lymphoma. Dogs with B-cell phenotype were 9 times as likely as dogs with T-cell phenotype to have a CR to chemotherapy in multicentric lymphomas (P = 0.089). Clinical substage, P-glycoprotein expression prior to chemo-therapy, and response to therapy were significantly associated with the survival time. Tumor lineage was determined in 66 lymphomas by IHC and PCR methods. As a result, multicentric lymphomas comprised 78.6% (44/56) B-cell and 12.5% (7/56) T-cell lymphomas, and 5 dogs (5/56; 8.9%) remained undetermined. All the 10 cutaneous lymphomas were of T-cell phenotype. Dual phenotype and genotype were separately found in two multicentric lymphomas. Overall, a higher sensitivity of IHC immuno-phenotyping than PCR clonality assay (93.4% versus 87.0%) in the determination of lineage was demonstrated in all lymphomas in the present study.
URI: http://hdl.handle.net/11455/12816
其他識別: U0005-0607201114203100
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-0607201114203100
Appears in Collections:獸醫學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.